Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
166.40
+17.29 (11.60%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Nutex Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 879.95 | 875.26 | 479.95 | 247.65 | 219.29 | 331.53 | |
Revenue Growth (YoY) | 40.95% | 82.36% | 93.80% | 12.93% | -33.85% | 20.98% |
Cost of Revenue | 462.28 | 430.98 | 283.69 | 212.87 | 203.87 | 152.25 |
Gross Profit | 417.67 | 444.28 | 196.26 | 34.77 | 15.42 | 179.28 |
Selling, General & Admin | 141.44 | 168.66 | 58.48 | 36.11 | 23.89 | 9.02 |
Other Operating Expenses | - | - | 7.08 | 30.44 | 398.14 | - |
Total Operating Expenses | 141.44 | 168.66 | 65.56 | 66.55 | 422.02 | 9.02 |
Operating Income | 276.23 | 275.63 | 130.7 | -31.77 | -406.6 | 170.27 |
Interest Expense | -20.79 | -22.23 | -19.93 | -16.32 | -12.49 | -6.2 |
Other Non-Operating Income (Expense) | 5.32 | 8.62 | 0.94 | 0.4 | 0.56 | -5.42 |
Total Non-Operating Income (Expense) | -15.47 | -13.61 | -18.99 | -15.92 | -11.93 | -11.62 |
Pretax Income | 250.13 | 244.78 | 109.83 | -48.49 | -419.65 | 169.49 |
Provision for Income Taxes | 57.81 | 64.42 | 15.02 | -5.07 | 13.09 | 0.97 |
Net Income | 192.31 | 180.36 | 94.81 | -43.42 | -432.74 | 168.53 |
Minority Interest in Earnings | 95.94 | 109.57 | 42.71 | 2.36 | -7.96 | 35.93 |
Net Income to Common | 96.38 | 70.79 | 52.1 | -45.79 | -424.78 | 132.59 |
Net Income Growth | 30.81% | 35.88% | - | - | - | 25.12% |
Shares Outstanding (Basic) | 7 | 6 | 5 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 7 | 7 | 5 | 4 | 4 | 4 |
Shares Change (YoY) | 27.98% | 23.02% | 24.57% | 1.70% | 9.69% | 11122.00% |
EPS (Basic) | 13.52 | 11.13 | 10.23 | -10.39 | 10.23 | -10.39 |
EPS (Diluted) | 12.94 | 10.48 | 9.69 | -10.39 | 9.69 | -10.39 |
EPS Growth | 2.21% | 8.15% | - | - | - | - |
Free Cash Flow | 269.02 | 245.6 | 20.85 | -8.24 | 35.97 | 136.51 |
Free Cash Flow Growth | 9.53% | 1077.99% | - | - | -73.65% | 435.68% |
Free Cash Flow Per Share | 36.12 | 36.35 | 3.80 | -1.87 | 8.30 | 34.54 |
Gross Margin | 47.47% | 50.76% | 40.89% | 14.04% | 7.03% | 54.08% |
Operating Margin | 31.39% | 31.49% | 27.23% | -12.83% | -185.41% | 51.36% |
Profit Margin | 21.86% | 20.61% | 19.75% | -17.53% | -197.33% | 50.83% |
FCF Margin | 30.57% | 28.06% | 4.34% | -3.33% | 16.40% | 41.17% |
EBITDA | 297.16 | 296.16 | 149.67 | -14.18 | -393.47 | 177.93 |
EBITDA Margin | 33.77% | 33.84% | 31.18% | -5.73% | -179.42% | 53.67% |
EBIT | 276.23 | 275.63 | 130.7 | -31.77 | -406.6 | 170.27 |
EBIT Margin | 31.39% | 31.49% | 27.23% | -12.83% | -185.41% | 51.36% |
Effective Tax Rate | 23.11% | 26.32% | 13.68% | 10.45% | -3.12% | 0.57% |